|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||187.42 - 188.79|
|52 Week Range||144.75 - 188.79|
|Beta (3Y Monthly)||1.03|
|PE Ratio (TTM)||20.20|
|Earnings Date||Apr 24, 2019 - Apr 29, 2019|
|Forward Dividend & Yield||2.08 (1.12%)|
|1y Target Est||189.59|
IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CET, February 19, 2019 - MDxHealth SA (Euronext:MDXH.BR), today announced the appointment of Michael K. McGarrity to the position of Chief Executive Officer and member of the Board of Directors effective February 19, 2019. Mr. McGarrity has more than 25 years of experience in the healthcare industry with a unique combination of device, diagnostics and biotechnology experience. Michael was most recently the CEO of Sterilis Medical.
Kalamazoo, Michigan – February 14, 2019 – Stryker (SYK) announced today it has been named one of Fortune’s 2019 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States. This is the ninth consecutive year Stryker has been named to the list, and the company was ranked #11. “We are one of the 100 Best Companies to Work For because of our people,” said Katy Fink, Vice President, Chief Human Resources Officer, Stryker.
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Stryker (SYK) will participate in the 8th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019 at the Lotte New York Palace in New York, New York. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 10:30 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site.
Stryker (SYK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The size of Stryker Corporation (NYSE:SYK), aRead More...
Stock funds rallied in January, leaving many investors with a Goldilocks stock market forecast: not too hot, not too cold.
Stryker Corp NYSE:SYKView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for SYK with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting SYK. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding SYK totaled $14.29 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. The dividend yield of Stryker Corp stocks is 1.08%. Stryker Corp had annual average EBITDA growth of 6.20% over the past ten years.
Kalamazoo, Michigan, Feb. 06, 2019 -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on April 30, 2019 to.
Abbott or Stryker: Which Is a Better Medtech Bet in This Month?(Continued from Prior Part)Growth driversOn its fourth-quarter earnings conference call, Stryker (SYK) said that it expects its MedSurg segment to be a major growth driver for it in 2019
Abbott or Stryker: Which Is a Better Medtech Bet in This Month?(Continued from Prior Part)Dividend trendsOn its fourth-quarter earnings conference call, Abbott Laboratories (ABT) guided for a dividend payout ratio of 40% or higher for future years.
Abbott or Stryker: Which Is a Better Medtech Bet in This Month?(Continued from Prior Part)Expense projections for 2019On its fourth-quarter conference call, Abbott Laboratories (ABT) guided for adjusted SG&A (selling, general, and
Abbott or Stryker: Which Is a Better Medtech Bet in This Month?(Continued from Prior Part)Margin projections for 2019On its fourth-quarter conference call, Abbott Laboratories (ABT) guided for an adjusted gross margin of 58.5% in the first quarter
Abbott or Stryker: Which Is a Better Medtech Bet in This Month?(Continued from Prior Part)Revenue guidance for 2019On its fourth-quarter conference call, Abbott Laboratories (ABT) stated that it expected its sales to grow organically by 6.5%–7.5%
Abbott or Stryker: Which Is a Better Medtech Bet in This Month?Stock price movementsOn February 1, Abbott Laboratories (ABT) closed at $72.36, 0.82% lower than its previous closing price, 30.19% higher than its 52-week low of $55.58, and 3.42% below
Medical device stocks remain supported by favorable conditions that should see sales grow. Watch these three stocks for a 52-week breakout.
General Dynamics Corp has been awarded a $402 million U.S. defense contract for Stryker system technical support services, the Pentagon said on Thursday.
NEW YORK, Jan. 31, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.